Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide
D'Onofrio, F.; Pempinello, R.; Romis, L.
Arzneimittel-Forschung 22(11): 1879-1881
1972
ISSN/ISBN: 0004-4172 PMID: 4679059 Document Number: 47552
Document emailed within 1 workday
Related Documents
Lentini, S.; Bossini, A.; Pirola, L.C. 1972: A controlled clinical trial of a new oral hypoglycemic agent, glipizide (K 4024) Arzneimittel-Forschung 22(7): 1169-1173Sieberová, R. 1971: Clinical experiences with administration of oral antidiabetic agent Buformin Casopis Lekaru Ceskych 110(18): 420-421
Leubner, H. 1973: Results of a clinical test on the oral antidiabetic agent glibornuride (Ro 6-4563) Wiener Medizinische Wochenschrift 123(17): 277-282
Behpour, A. 1980: Diabetes in adults and old age. Treatment with an oral antidiabetic agent Zfa. Zeitschrift für Allgemeinmedizin 56(22): 1412-1414
Stańczyk, J.; Otto-Buczkowska, E.; Jarosz-Chobot, P.ła.; Nowowiejska, B. 2008: Used of oral antidiabetic agents in pediatric patients - own observations Endokrynologia Polska 59(5): 434-443
Uglesic, A.; Ljahnicky, N. 1975: Experiences with the oral antidiabetic agent, Glurenorm, in diabetics with kidney diseases Medizinische Monatsschrift 29(9): 408-411
Schmitt, E.W.; Nijssen, J. 1978: Glibornuride--field study on an oral antidiabetic agent. Results of therapy with gluboride in a large number of patients Die Medizinische Welt 29(29-30): 1170-1174
Voss, D.; Fuchs, G.; Schneider, D.; Schneider, J. 1972: Effect of the oral antidiabetic agent glibornuride on blood coagulation, blood platelets, and fibrinolysis Arzneimittel-Forschung 22(Suppl 12a): 2219
Dhirawani, M.K.; Patel, J.C.; Kabadi, U.M. 1970: A clinical trial with glycodiazine--a new oral antidiabetic compound Indian Journal of Medical Sciences 24(2): 53-62
Remy, C.; Schoos, R.; Luyckx, A.; Lefèbvre, P. 1980: Determination of hemoglobin A1c for the evaluation of metabolic equilibrium in patients with non-insulin-dependent diabetes treated with glipizide Revue Medicale de Liege 35(10): 393-398
Maeshiba, Y.; Kiyota, Y.; Yamashita, K.; Yoshimura, Y.; Motohashi, M.; Tanayama, S. 1997: Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys Arzneimittel-Forschung 47(1): 29-35
Wright, G.J.; Hook, R.H.; Blackwell, B. 1974: Metabolic and clinical observations on metiapine in humans Advances in Biochemical Psychopharmacology 9: 445-455
Grujić, M.; Rizvanbegović, B.; Perinović, M.; Perinović, I.D. 1976: Glurenorm a new peroral antidiabetic agent belonging to the group of sulfonylurea compounds Medicinski Arhiv 30(2): 119-121
Brandt, S. 2013: The clinical effects of zinc as a topical or oral agent on the clinical response and pathophysiologic mechanisms of acne: a systematic review of the literature Journal of Drugs in Dermatology: Jdd 12(5): 542-545
Hepp, K.D. 1983: Fenfluramine as an oral antidiabetic Münchener Medizinische Wochenschrift 125(46): 126-127
Johansen, K. 2001: New oral antidiabetic glitazones Ugeskrift for Laeger 164(1): 76-77
Ahmed, H.M. 1975: Effect of calcium chloride on some metabolic actions of certain antidiabetic drugs in normal and alloxanised rabbits Die Pharmazie 30(9): 598-602
Schroner, Z.; Javorsky, M.; Kozarova, M.; Tkac, I. 2011: Pharmacogenetics of oral antidiabetic treatment Bratislavske Lekarske Listy 112(8): 441-446
Haslbeck, M. 1979: New aspects of therapy with oral antidiabetic agents Wiener Medizinische Wochenschrift 199(24): 689-695
Koivisto, V. 1999: Insulin analogs and new oral antidiabetic drugs Duodecim; Laaketieteellinen Aikakauskirja 115(20): 2197-2202